The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events

被引：0
|
作者：
Gennaro Galasso
Gaetano Santulli
Federico Piscione
Roberta De Rosa
Valentina Trimarco
Raffaele Piccolo
Salvatore Cassese
Guido Iaccarino
Bruno Trimarco
Massimo Chiariello
机构：
[1] Federico II University School of Medicine,Department of Clinical Medicine, Cardiovascular and Immunologic Sciences
来源：
BMC Cardiovascular Disorders | / 10卷
关键词：
Percutaneous Coronary Intervention; Acute Myocardial Infarction; Transient Ischemic Attack; Peripheral Artery Disease; Major Adverse Cardiac Event;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Platelet PlA2 polymorphism and platelet activation are associated with increased troponin I release after cardiopulmonary bypass
    Rinder, CS
    Mathew, JP
    Rinder, HM
    Howe, JG
    Fontes, M
    Crouch, J
    Pfau, S
    Patel, P
    Smith, BR
    ANESTHESIOLOGY, 2002, 97 (05) : 1118 - 1122
  • [22] Platelet GPIIIa PLA polymorphism and incident cardiovascular disease: The Framingham Heart Study
    Feng, DL
    Larson, MG
    Lindpaintner, K
    O'Donnell, CJ
    Mittleman, M
    Lipinska, I
    D'Agostino, RB
    Levy, D
    Tofler, GH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 304A - 304A
  • [23] Increased activity of phosphatase PP2A in the presence of the PlA2 polymorphism of αIIbβ3
    Wang, Huill
    Yan, Bin
    Satterwhite, Lisa L.
    Ma, Qi
    Goldschmidt-Clermont, Pascal J.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 367 (01) : 72 - 77
  • [24] Is rosiglitazone associated with increased risk for cardiovascular events?
    Hanefeld, M.
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2007, 4 (12): : 648 - 649
  • [25] Is rosiglitazone associated with increased risk for cardiovascular events?
    Markolf Hanefeld
    Nature Clinical Practice Cardiovascular Medicine, 2007, 4 : 648 - 649
  • [26] Increased binding of soluble fibrinogen to the platelet glycoprotein (GP) IIb-IIIa receptor related to the polymorphism of the GPIIIa gene (HPA-1b, PLA2).
    Scharf, RE
    Deitenbeck, R
    Giers, G
    Zotz, RB
    BLOOD, 1997, 90 (10) : 1124 - 1124
  • [27] Platelet glycoprotein IIb/IIIa PlA2/PlA2 homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men -: The Copenhagen City Heart Study
    Bojesen, SE
    Juul, K
    Schnohr, P
    Tybjærg-Hansen, A
    Nordestgaard, BG
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (04) : 661 - 667
  • [28] Aggressive antiplatelet therapy reduces the risk of coronary stent thrombosis associated with the GPIIb/IIIa PLA2 polymorphism
    Walter, DH
    Elsner, M
    Goette, S
    Auch-Schwelk, W
    CIRCULATION, 1999, 100 (18) : 709 - 710
  • [29] Increased PLA2 activity in individuals at ultra-high risk for psychosis
    Talib, Leda L.
    Costa, Alana C.
    Joaquim, Helena P. G.
    Pereira, Cicero A. C.
    van de Bilt, Martinus T.
    Loch, Alexandre A.
    Gattaz, Wagner F.
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2021, 271 (08) : 1593 - 1599
  • [30] Increased PLA2 activity in individuals at ultra-high risk for psychosis
    Leda L. Talib
    Alana C. Costa
    Helena P. G. Joaquim
    Cícero A. C. Pereira
    Martinus T. Van de Bilt
    Alexandre A. Loch
    Wagner F. Gattaz
    European Archives of Psychiatry and Clinical Neuroscience, 2021, 271 : 1593 - 1599
12345